https://journals.sbmu.ac.ir/jcma/issue/feed Journal of Cellular & Molecular Anesthesia 2021-01-24T16:37:03+00:00 Ali Dabbagh, MD alidabbagh@sbmu.ac.ir Open Journal Systems <p><strong style="font-style: italic;">Journal of Cellular and Molecular Anesthesia (JCMA)</strong> is a quarterly, peer-reviewed journal, with particular attention to translational anesthesiology and perioperative medicine. Disease-oriented basic research in cellular and molecular aspects of anesthesiology, including laboratory investigations, bench to bedside studies, or clinical researches that yield new findings in molecular and cellular anesthesia and improve our diagnosis and therapeutics in clinical anesthesia are among the main targets in JCMA. Researches about Personalized Anesthesiology and Perioperative Medicine are another main area of interest in JCMA.</p> https://journals.sbmu.ac.ir/jcma/article/view/33264 Cellular and Molecular Approaches to COVID-19: “Road to Perdition” or “The Shawshank Redemption” 2020-12-14T16:32:00+00:00 Ali Dabbagh alidabbagh@sbmu.ac.ir 2020-12-11T18:56:14+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/33199 Dexmedetomidine or Clonidine: Action Expresses Priorities 2020-12-14T16:32:00+00:00 Alireza Mirkheshti a_mirkheshti@sbmu.ac.ir 2020-12-08T18:17:26+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/32096 Regulatory Effects of Thymoquinone on Dopamine Level in Neuronal Cells Exposed to Amphetamine: An In Vitro Study 2020-12-14T16:32:00+00:00 Nurul Farah Aina Md Fauzi nurulfaina92@gmail.com Nor Hidayah Abu Bakar norhidayahabubakar@unisza.edu.my Nasir Mohamad drnasirmohamadkb@yahoo.com Liyana Hazwani Mohd Adnan liyanahazwani@unisza.edu.my Nor Suliana Mustafa nurulfaina92@gmail.com Nor Zidah Ahmad nurulfaina92@gmail.com <p><strong>Introduction: </strong>Amphetamine (AT) is used to treat some medical conditions and also known to be abused recreationally. It is a potent central nervous system stimulant that is capable of producing damaging effects to the central dopaminergic pathway. Most of AT users are treated clinically for symptomatic treatment which is associated with neurological side effects. To date, there is growing interest in naturally occurring compounds which have lesser side effects to treat health problems. One of the potential compounds is thymoquinone (TQ), an active compound of <em>Nigella sativa</em> which is known for its cellular protective effects. <strong>Objective:</strong> The objectives of this study were to determine the IC<sub>50</sub> values of AT and TQ on differentiated SH-SY5Y neuronal cells and to evaluate the changes of dopamine (DA) level in the cells exposed to AT after co-administering with TQ. <strong>Methodology: </strong>Differentiated SH-SY5Y cells were grown in cell culture flask containing DMEM/F12 medium supplemented with 10% (v/v) fetal bovine serum and 1% (v/v) penicillin/streptomycin. The IC<sub>50 </sub>value of TQ and AT in differentiated SH-SY5Y cells was determined by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The DA level was determined by using the Enzyme-Linked Immunosorbent Assay (ELISA) kit. <strong>Result and Discussion:</strong> The IC<sub>50</sub> values of AT and TQ were 1596 µM and 926 µM respectively. Co-administration of 40 µM of AT and 30 µM of TQ demonstrated a significant increase in DA level at 48 hours of exposure when compared to the administration of AT group (<em>P</em>≤0.05). <strong>Conclusion:</strong> These findings suggested that TQ has a role in maintaining the DA activity after a long-term AT exposure.</p> 2020-09-23T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31852 The Founder Effect? -FXIII Deficiency in Southeast Iran: A Molecular Study Report 2020-12-25T05:44:00+00:00 Hojat Shahraki Hojat93.shahraki@gmail.com Akbar Dorgalaleh dorgalaleha@gmail.com Majid Fathi mustanges36@gmail.com Shadi Tabibian Sh.tabibian@gmail.com Shahram Teimourian Sh.teumorian@gmail.com Hasan Mollanoori hasan_mollanoori@yahoo.com Farhad Zaker farhadz20@yahoo.co.uk <h2>Background: Congenital factor XIII (FXIII) deficiency is an extremely rare bleeding disorder (RBD) with different clinical coagulation disorders and great impacts on the perioperative patient outcome. Its prevalence in Southeast Iran is approximately 4,000 times higher than the worldwide prevalence, with Trp187Arg (c.559T&gt; C as the only causative mutation of FXIIID there. We investigated the founder effect of rs1742924, rs4960181, rs3778360 and rs4142290 using haplotype analysis to define the genetic phenomenon in this geographic region.</h2> <h2>Materials and Methods: In a case-control study, 10 patients with FXIIID and 10 healthy individuals were assessed. Initially, Trp187Arg (c.559T&gt; C) mutation was assessed in all study populations using a PCR-RFLP technique, then haplotype analysis was performed by assessing rs1742924, rs4960181, rs3778360 and rs4142290 polymorphisms. Data were analyzed using a two-proportion z-test.</h2> <h2>Results: All patients were homozygote for Trp187Arg (c.559T&gt;C), and this mutation was not observed in any form of homozygote or heterozygote in the control group. Polymorphisms in rs1742924, rs4960181, and rs377836 were homozygote (TT, GG, GG, respectively) and T, G, and G alleles distribution in cases and controls with significant difference (P&lt;0.001, P&lt;0.001, and P=0.01 respectively). Rs4142290 polymorphism showed no significant difference between patients and controls (P=0.3). Two types of haplotypes were observed in the case group, and haplotype number 1* was observed among 90% of them, while not observed in the control group.</h2> <h2>Conclusion: It seems that founder effectors of haplotype number *1 have more antiquity versus other haplotypes, and probably founder effect is responsible for this high prevalence of FXIIID in the southeast of Iran.</h2> 2020-09-22T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/32015 Effect of Scalp Block on Postoperative nausea and vomiting & Recovery Profile after Craniotomy: A Randomized, Double-Blind, Controlled Study 2020-12-14T16:32:00+00:00 Raham Hasan Mostafa rahamhasan@yahoo.com Mohamed Abdel-Fattah Ghoneim demerdash1975@gmail.com Doaa Mohammed Kamal EL-Din mkjamaluddeen@hotmail.com Mohamed Abdulmohsen Abdulnaiem Ismaiel mohamedismaiel79@gmail.com Ibrahim Abdelmohsen abdolmohsen80@gmail.com Sameh Ahmed Refaat sameh_refaat@med.asu.edu.eg <p><strong>Background</strong>:</p> <p>Scalp block with bupivacaine has shown to provide perioperative analgesia with subsequent decrease in intraoperative opioids consumption. We performed a prospective randomized controlled study to evaluate the efficacy of preemptive scalp block in preventing Postoperative nausea and vomiting (PONV) after elective supratentorial craniotomy</p> <p><strong>Methods:</strong></p> <p>40 patients were randomly allocated to either control group or preemptive scalp block group. Postoperative nausea &amp; vomiting incidence &amp; severity during 1<sup>st</sup> 24 hours after operation were recorded.</p> <p><strong>Results</strong>:</p> <p>We found that PONV% was statistically insignificant between the 2 groups; 50% in control group, 45% in Scalp block group. On the other hand, Scalp block blunted response of both mean arterial blood pressure and heart rate with noxious stimuli during pinning and skin incision together with improvement in recovery profile.</p> <p><strong>Conclusions</strong>:</p> <p>Scalp block, combined with general anesthesia provided good hemodynamic stability &nbsp;and better recovery profile during craniotomy but on the other hand, &nbsp;had no effect on PONV incidence during 1<sup>st</sup> 24 h.</p> 2020-09-29T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/32430 Toll-Like Receptor 4 in Acute Respiratory Distress Syndrome: Good Time to Target? 2020-12-14T16:32:00+00:00 Bahador Bagheri bahadordvm@yahoo.com Mohammad Torabi sarasalarian@yahoo.com Sara Salarian sarasalarian@yahoo.com <p><strong><em>A</em></strong>cute respiratory distress syndrome (ARDS) is considered a major cause of death in the world. ARDS is defined by life-threatening pulmonary edema and hypoxemia with <strong><em>a </em></strong>mortality rate <strong><em>of </em></strong>up to 40%. Recent advances in understating cellular aspects of the syndrome have shed light on possible new treatments and reduction of mortality. Toll-like receptors (TLRs) are <strong><em>p</em></strong>attern recognition receptors (PRRs) involved in adaptive and innate immunity. They are present in the alveoli and their activation can lead to inflammatory responses and finally acute lung injury. Among them, Toll<strong><em>-</em></strong>like receptor 4 (TLR4) is abundantly available on the epithelial cells of the alveoli and also on resident monocytes. TLR4 is one of the players that can promote alveolar damages during ARDS. Here, we focus on <strong><em>the </em></strong>TLR4 role in ARDS pathophysiology. We also present the potential therapies for the syndrome based on TLR4 inhibition.</p> 2020-10-17T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/30725 Dexmedetomidine in Neurocritical Care 2020-12-14T16:32:01+00:00 Mohammadreza Hajiesmaeili drhajiesmaeili@gmail.com Leila Simani l.simani62@gmail.com Razieh Hajisoltani razieh.hajisoltani@gmail.com Reza Goharani r.goharani@sbmu.ac.ir Masood Zangi leila.simani@yahoo.com Mahdi Amirdosara mahdi_0597@yahoo.com Majid Mokhtari m.mokhtari@sbmu.ac.ir <p>Early and appropriate management of brain insults has significantly reduced patient morbidity and mortality. Neuromonitoring, neuroprotection and secondary brain injury prevention are the essential principals of brain injury management.</p> <p>In this literature review we have elaborated the neuroprotective role of dexmedetomidine (DEX), predominantly in different animal models of brain insults and reports in patients cared in a neurocritical care setting. &nbsp;We undertook an electronic literature search of articles published in English prior to July 2019. This search resulted in inclusion of 59 studies from medical databanks such as PubMed, Scopus, EMBSCO, CINAHL, ISC and the Cochrane Library. The keywords used were brain, α<sub>2</sub> agonist, neurocritical care and dexmedetomidine.</p> <p>DEX may have a neuroprotective effect in a broad spectrum of brain pathologies such as traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), ischemic stroke, intracerebral hemorrhage (ICH), and cerebral hypoxia. However, its neuroprotective role in status epilepticus (SE) is less clear. Further animal and human studies are needed before we could consider DEX as a neuroprotective agent in this patient population. Due to its favorable properties outlined in this review, DEX could be considered a favorable sedative agent in the neurocritical care settings.</p> 2020-06-14T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31845 Surgical Music Therapy: A Narrative Review 2020-12-14T16:32:00+00:00 Khashayar Shahriyari khashayar.shahriyari@gmail.com Parisa Sezari parissasezari@yahoo.com <p>This study is aimed to review the documents and clarify the relation between music therapy and surgical procedures.</p> <p>Surgical procedures are often accompanied by psychological feelings such as fear and anxiety, which can affect the anesthesia process and lead to increased sedation and undesirable physiological and metabolic changes. These changes can cause deleterious effects when exaggerated.</p> <p>According to neuroscience-based evidences, music can activate limbic and paralimbic brain structures, which play a role in changing the emotional state. In conclusion, music could help to alleviate unwanted feelings and control surgical stress.</p> 2020-09-23T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31349 Coronavirus Disease 2019 (COVID-19): Immune Responses, Transmission and Clinical features: An Update 2021-01-24T16:37:03+00:00 Parastoo Hosseini p_h817@yahoo.com Amin Dehghan amin_dehghan25@yahoo.com Azadeh Haghi Navand azadeh.haghi.navand@gmail.com Mona Moghadami mona_mo81@yahoo.com Saber Soltani sabersoltani71@gmail.com Milad Zandi miladzandi416@gmail.com <p>A novel beta-coronavirus was reported in Wuhan, Hubei Province, China, which in December 2019, named SARS-CoV-2.&nbsp; It causes Coronavirus Disease 2019 (COVID-19) that can affect lung tissue and airways. The immune system can respond to SARS-CoV-2 infection via various mechanisms. Cytokines play crucial roles in COVID-19. In the present study, the latest information on the immune responses, transmission, symptoms, diagnosis, and treatment of COVID-19 is reviewed.</p> 2020-12-13T13:28:28+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31742 Emergency surgery in the prone position in a COVID-19 suspect: A challenge to the Anesthesiologist 2020-12-14T16:32:01+00:00 Sanjeeb Kumar Giri bikunrs77@gmail.com Abhishek Singh bikunrs77@gmail.com Pragya Preet Kaur bikunrs77@gmail.com Rashmi Ramachandran bikunrs77@gmail.com <p>Covid-19 has officially declared a pandemic by the World Health Organization.&nbsp; Various societies around the world have given their recommendation for the safe conduct of anesthesia and surgery during the pandemic, but little has been discussed regarding the various positions of surgery and their implications. We report our experience of managing a COVID suspect patient in an emergency operation theater in a prone position.</p> 2020-09-05T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31261 Neurologic Manifestations of COVID-19: A Case Series of Iranian Patients 2020-12-14T16:32:00+00:00 Farhad Malek malekf@semums.ac.ir Nooshin Masoodian masoodianm@semums.ac.ir Afshin Samaei samaeia@semums.ac.ir Ali Gohari goharia@semums.ac.ir Sara Reshadat reshadat@semums.ac.ir Hoda Aryan darbanm@semums.ac.ir Mohammad Memarian darbanm@semums.ac.ir Mahboubeh Darban dr.mdarban@gmail.com Bahador Bagheri bahadordvm@yahoo.com <p class="p1"><span class="s1"><strong>Introduction:</strong></span><span class="s2">&nbsp;S</span><span class="s3">evere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is declared a pandemic disease by </span><span class="s2">the World Health Organization. </span><span class="s3">Although the respiratory and cardiovascular systems are preferentially affected by SARS-CoV-2, many patients have been presented with neurologic symptoms</span><span class="s2">. In this report, we describe COVID-19 patients with neurological manifestations.</span></p> <p class="p2"><span class="s1"><strong>Case Presentation:</strong></span><span class="s2">&nbsp;We present 14 patients referred to Semnan Kowsar Hospital. The mean age at presentation was 54.25 </span><span class="s4">± </span><span class="s2">20.01 years with a range of 24-84 yr. At admission, they had mild symptoms of respiratory involvement. In contrast, they had a wide range of neurological conditions like impaired consciousness, seizure, stroke, ataxia, and muscle numbness. After hospitalization, they developed overt respiratory symptoms. They were positive for COVID-19 confirmed by real-time PCR. All cases received standard care of COVID-19.</span></p> <p class="p3"><span class="s1"><strong>Conclusions:</strong></span><span class="s2"> During the&nbsp;</span><span class="s3">SARS-CoV-2 pandemic disease, patients with neurological manifestations might be affected by coronavirus. Such patients should be thoroughly evaluated and followed-up.</span></p> 2020-10-01T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31741 Brief Ultraviolet Irradiation Before Doffing May Prevent Transmission of Infection due to COVID-19 2020-12-14T16:32:01+00:00 Sanjeeb Kumar Giri bikunrs77@gmail.com Abhishek Singh bikunrs77@gmail.com Puneet Khanna bikunrs77@gmail.com <p>&nbsp;</p> <p>The confirmed cases of COVID-19 is showing exponential increase every day. Healthcare workers throughout the work are giving their best to contain the spread of disease. COVID-19 has not only affected common people, but healthcare workers are also getting infected despite following full precaution. In this article we suggest that brief ultraviolet C irradiation before doffing may help to decrease the incidence of infection among healthcare workers due to error in doffing process.</p> 2020-09-04T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/33108 Ketamine, Xylazine, and Thiopental: Safety versus Study Design in Animal Anesthesia Models 2020-12-14T16:32:00+00:00 Firoozeh Madadi fmadadi33@gmail.com 2020-12-04T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/32344 Role of IL-4 in Cytokine Storm Syndrome due to COVID-19 Infection 2021-01-09T18:11:23+00:00 Rahim Soleimani Jelodar rahimsoleimani1361@yahoo.com Sepideh Nasimzadeh snasimzade@gmail.com Amin Dehghan amin_dehghan25@yahoo.com Milad Zandi miladzandi416@gmail.com <p>SARS-CoV-2 that causes Coronavirus disease 2019 (COVID-19) is a spreading global threat. COVID-19 declared as a pandemic by the WHO. COVID-19 is transmitted by direct contact or droplets and can infect the respiratory tract which resulting in acute respiratory distress syndrome (ARDS) and pneumonia in most of cases. IL-4 as a Th2 cytokines has different roles in coronaviruses infections. In this article we focused on function of IL-4 in COVID-19.</p> 2020-10-01T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/30911 Electroconvulsive Therapy During the Coronavirus Pandemic 2020-12-14T16:32:01+00:00 Abhishek Singh bikunrs77@gmail.com Puneet Khanna bikunrs77@gmail.com 2020-07-22T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/32025 Relationship between ABO Blood Group Type and COVID-19 Outcome in Pregnant Women 2021-01-08T08:03:57+00:00 Monireh Mirzaie mahboubeh.yousefi@yahoo.com Hamed Shafie mahboubeh.yousefi@yahoo.com Reza Heidarifar reza.he68@yahoo.com Maryam Sadat Yousefi maryamsadatyousefi@yahoo.com Mahboubeh Sadat Yousefi mahboubeh.yousefi@yahoo.com 2020-09-23T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/32113 The Potential Role of Bromelain in the Treatment of SARS-COV-2 2020-12-14T16:32:01+00:00 Kurdistan Sharifzadeh kurdistan_sh@yahoo.com Behrooz Farzanegan farzaneganbehrooz@gmail.com Seyed Bashir Mirtajani bashirmirtajani67@gmail.com Farzad Peyravian peiravianfarzad@gmail.com Alireza Jahangirifard alirezajahangiri@sbmu.ac.ir <p>.</p> 2020-09-22T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31768 The Labor Pain Management Challenges During the COVID-19 Pandemic: An Iranian Experience 2020-12-14T16:32:01+00:00 Ehsan Bastanhagh e-bastanhagh@sina.tums.ac.ir Saghar Samimi Sadeh sagharsamimi@yahoo.com Alireza Behseresht a-behseresht@razi.tums.ac.ir 2020-09-22T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia https://journals.sbmu.ac.ir/jcma/article/view/31766 Hospital Preparedness and Protection Plans in COVID-19 Pandemic 2020-12-14T16:32:01+00:00 Farhad Hamzezadeh f.hamzehzadeh99@gmail.com Fateme Mirzaee mirzaee.to@gmail.com Hamidreza Aslani hraslani@yahoo.com 2020-09-05T00:00:00+00:00 Copyright (c) 2020 Journal of Cellular & Molecular Anesthesia